Clinical Trials Logo

Clinical Trial Summary

Clinical trial to investigate the safety, tolerability and pharmacokinetics and pharmacodynamics of JP-1366 oral administration in healthy male subjects


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03383042
Study type Interventional
Source Jeil Pharmaceutical Co., Ltd.
Contact
Status Completed
Phase Phase 1
Start date December 22, 2017
Completion date April 5, 2019

See also
  Status Clinical Trial Phase
Completed NCT05181124 - Compare Pharmacokinetics and Safety of JP-1366 Between Korean and Caucasian Phase 1